• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment.

作者信息

Makras Polyzois, Yavropoulou Maria P, Anastasilakis Athanasios D, Papatheodorou Athanasios, Tekedis Christos, Papapoulos Socrates E

机构信息

Department of Medical Research, 251 Hellenic Air Force & VA General Hospital, 3 Kanellopoulou St, 11525, Athens, Greece.

Department of Endocrinology and Diabetes, 251 Hellenic Air Force & VA General Hospital, Athens, Greece.

出版信息

Osteoporos Int. 2024 Apr;35(4):741-743. doi: 10.1007/s00198-023-07000-5. Epub 2023 Dec 26.

DOI:10.1007/s00198-023-07000-5
PMID:38147135
Abstract
摘要

相似文献

1
Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment.停用地诺单抗并换用阿仑膦酸盐治疗后出现的髋部短暂性骨质疏松症。
Osteoporos Int. 2024 Apr;35(4):741-743. doi: 10.1007/s00198-023-07000-5. Epub 2023 Dec 26.
2
Alendronate after denosumab discontinuation in women previously exposed to bisphosphonates was not effective in preventing the risk of spontaneous multiple vertebral fractures: two case reports.地舒单抗停药后应用阿仑膦酸钠对既往接受过双膦酸盐治疗的女性预防自发性多发椎体骨折无效：两例报告。
Osteoporos Int. 2019 May;30(5):1111-1115. doi: 10.1007/s00198-018-04820-8. Epub 2019 Jan 6.
3
Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study.地舒单抗对比利塞膦酸盐在阿仑膦酸钠治疗不依从的绝经后妇女中的疗效和安全性：一项随机、开放标签研究结果。
Bone. 2014 Jan;58:48-54. doi: 10.1016/j.bone.2013.10.006. Epub 2013 Oct 17.
4
Bone Mineral Density After Transitioning From Denosumab to Alendronate.从地舒单抗转换为阿仑膦酸钠后骨密度的变化。
J Clin Endocrinol Metab. 2020 Mar 1;105(3):e255-64. doi: 10.1210/clinem/dgz095.
5
Comparative effectiveness of denosumab vs alendronate among postmenopausal women with osteoporosis.绝经后骨质疏松症女性中地舒单抗与阿仑膦酸钠的疗效比较。
J Bone Miner Res. 2024 Aug 5;39(7):826-834. doi: 10.1093/jbmr/zjae079.
6
The Clinical Effectiveness of Denosumab (Prolia®) for the Treatment of Osteoporosis in Postmenopausal Women, Compared to Bisphosphonates, Selective Estrogen Receptor Modulators (SERM), and Placebo: A Systematic Review and Network Meta-Analysis.唑来膦酸（普罗力）治疗绝经后妇女骨质疏松症的临床疗效：与双膦酸盐、选择性雌激素受体调节剂（SERM）和安慰剂的系统评价和网络荟萃分析。
Calcif Tissue Int. 2023 Jun;112(6):631-646. doi: 10.1007/s00223-023-01078-z. Epub 2023 Apr 5.
7
Cost-effectiveness analysis of drugs for osteoporosis treatment in elderly Japanese women at high risk of fragility fractures: comparison of denosumab and weekly alendronate.用于治疗老年日本女性脆性骨折高危人群骨质疏松症药物的成本效果分析：地舒单抗与每周阿仑膦酸钠的比较。
Arch Osteoporos. 2018 Aug 29;13(1):94. doi: 10.1007/s11657-018-0509-6.
8
Denosumab: a review of its use in the treatment of postmenopausal osteoporosis.地舒单抗：用于治疗绝经后骨质疏松症的研究综述。
Drugs Aging. 2011 Jan 1;28(1):63-82. doi: 10.2165/11203300-000000000-00000.
9
One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study.不同抗骨质疏松药物的一年和两年持续治疗情况：一项回顾性队列研究。
Osteoporos Int. 2017 Oct;28(10):2997-3004. doi: 10.1007/s00198-017-4144-7. Epub 2017 Jul 16.
10
Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis--usefulness of alendronate and risedronate.抗骨折药物在绝经后、男性及糖皮质激素诱导的骨质疏松症中的作用——阿仑膦酸盐和利塞膦酸盐的效用
Expert Opin Pharmacother. 2007 Nov;8(16):2743-56. doi: 10.1517/14656566.8.16.2743.

本文引用的文献

1
Letter to the editor regarding "Comparison of various treatment modalities for the management of bone marrow edema syndrome or transient osteoporosis in men and nonpregnant women: a systematic review".
Osteoporos Int. 2023 Apr;34(4):817-818. doi: 10.1007/s00198-023-06705-x. Epub 2023 Feb 22.
2
Comparison of various treatment modalities for the management of bone marrow edema syndrome/transient osteoporosis in men and non-pregnant women: a systematic review.男性和非妊娠女性骨髓水肿综合征/暂时性骨质疏松症各种治疗方式的比较：一项系统评价
Osteoporos Int. 2023 Feb;34(2):269-290. doi: 10.1007/s00198-022-06584-8. Epub 2022 Nov 12.
3
The Duration of Denosumab Treatment and the Efficacy of Zoledronate to Preserve Bone Mineral Density After Its Discontinuation.地舒单抗治疗持续时间和唑来膦酸在停药后维持骨密度的疗效。
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e4155-e4162. doi: 10.1210/clinem/dgab321.
4
Regional osteoporosis due to osteoclast activation as a trigger for the pain-like behaviors in tail-suspended mice.破骨细胞激活导致的局部骨质疏松作为尾部悬吊小鼠疼痛样行为的触发因素。
J Orthop Res. 2017 Jun;35(6):1226-1236. doi: 10.1002/jor.23373. Epub 2017 Mar 8.
5
Transient osteoporosis of the hip, complete resolution after treatment with alendronate as observed by MRI description of eight cases and review of the literature.MRI 观察到的阿仑膦酸钠治疗后完全缓解的髋关节一过性骨质疏松症：8 例病例描述及文献复习。
Clin Rheumatol. 2012 Nov;31(11):1641-7. doi: 10.1007/s10067-012-2060-y. Epub 2012 Aug 30.
6
Biochemical markers of bone metabolism in bone marrow edema syndrome of the hip.髋部骨髓水肿综合征中骨代谢的生化标志物。
Bone. 2003 Sep;33(3):346-51. doi: 10.1016/s8756-3282(03)00164-9.
7
Intravenous pamidronate in the treatment of transient osteoporosis of the hip.静脉注射帕米膦酸盐治疗髋部短暂性骨质疏松症。
Bone. 2002 Jul;31(1):96-101. doi: 10.1016/s8756-3282(02)00812-8.
8
The pathology of transient regional osteoporosis.短暂性区域性骨质疏松症的病理学
Iowa Orthop J. 1998;18:35-42.